The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases - PubMed (original) (raw)
Review
. 2018 Jan;67(1):328-357.
doi: 10.1002/hep.29367. Epub 2017 Sep 29.
Affiliations
- PMID: 28714183
- DOI: 10.1002/hep.29367
Review
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al. Hepatology. 2018 Jan.
No abstract available
Comment in
- Reply.
Chalasani N; Writing Group for the AASLD NAFLD Practice Gudiance. Chalasani N, et al. Hepatology. 2018 Jun;67(6):2478-2479. doi: 10.1002/hep.29841. Epub 2018 Apr 26. Hepatology. 2018. PMID: 29443382 No abstract available. - Should statins be discontinued in cirrhosis with decompensation?
Carey W. Carey W. Hepatology. 2018 Jun;67(6):2477-2478. doi: 10.1002/hep.29842. Epub 2018 Apr 26. Hepatology. 2018. PMID: 29443384 No abstract available. - Recommendations for the Evaluation for Autoimmune Liver Disease in Nonalcoholic Fatty Liver Disease.
Cummings D, Ferstenberg R. Cummings D, et al. Hepatology. 2018 Sep;68(3):1203. doi: 10.1002/hep.30057. Epub 2018 Aug 31. Hepatology. 2018. PMID: 29694671 No abstract available.
Similar articles
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
Younossi ZM. Younossi ZM. Liver Transpl. 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003. Liver Transpl. 2018. PMID: 29272073 - Nonalcoholic Fatty Liver Disease.
Filipović B, Forbes A, Tepeš B, Dumitraşcu DL. Filipović B, et al. Can J Gastroenterol Hepatol. 2018 Jul 31;2018:2097435. doi: 10.1155/2018/2097435. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30155450 Free PMC article. No abstract available. - [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C, Zhou D, Fan J. Zhu C, et al. Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):81-4. doi: 10.3760/cma.j.issn.1007-3418.2016.02.001. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 26983471 Chinese. - Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.
Middleton JP, Wiener RC, Barnes BH, Gurka MJ, DeBoer MD. Middleton JP, et al. Clin Pediatr (Phila). 2014 Dec;53(14):1318-25. doi: 10.1177/0009922813520072. Epub 2014 Jan 28. Clin Pediatr (Phila). 2014. PMID: 24477713 Free PMC article. Review. No abstract available. - The Future of Nonalcoholic Fatty Liver Disease Treatment.
Mazhar K. Mazhar K. Med Clin North Am. 2019 Jan;103(1):57-69. doi: 10.1016/j.mcna.2018.08.005. Epub 2018 Nov 1. Med Clin North Am. 2019. PMID: 30466676 Review.
Cited by
- Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian Individuals with Type 2 Diabetes Mellitus.
Deb R, Goswami S, Sengupta N, Baidya A, Khare VR, Datta J, Jhaveri K, Das M, Ray D. Deb R, et al. Indian J Endocrinol Metab. 2024 Jul-Aug;28(4):385-390. doi: 10.4103/ijem.ijem_203_23. Epub 2024 Jun 6. Indian J Endocrinol Metab. 2024. PMID: 39371654 Free PMC article. - Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances.
Kumar AR, Nair B, Kamath AJ, Nath LR, Calina D, Sharifi-Rad J. Kumar AR, et al. Eur J Med Res. 2024 Oct 5;29(1):485. doi: 10.1186/s40001-024-02072-3. Eur J Med Res. 2024. PMID: 39367507 Free PMC article. Review. - Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH.
Schmidt-Christensen A, Eriksson G, Laprade WM, Pirzamanbein B, Hörnberg M, Linde K, Nilsson J, Skarsfeldt M, Leeming DJ, Mokso R, Verezhak M, Dahl A, Dahl V, Önnerhag K, Oghazi MR, Mayans S, Holmberg D. Schmidt-Christensen A, et al. Sci Rep. 2024 Oct 3;14(1):23014. doi: 10.1038/s41598-024-73150-z. Sci Rep. 2024. PMID: 39362932 Free PMC article. - Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease.
Chen LZ, Jing XB, Chen X, Xie YC, Chen Y, Cai XB. Chen LZ, et al. Rev Cardiovasc Med. 2024 Sep 24;25(9):344. doi: 10.31083/j.rcm2509344. eCollection 2024 Sep. Rev Cardiovasc Med. 2024. PMID: 39355605 Free PMC article. Review. - Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.
Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N. Lu X, et al. Signal Transduct Target Ther. 2024 Oct 2;9(1):262. doi: 10.1038/s41392-024-01951-9. Signal Transduct Target Ther. 2024. PMID: 39353925 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical